Data protection Impressum

Life sciences

The .NeuroRestore center in Lausanne, led by Jocelyne Bloch and Grégoire Courtine, has been honored with the 2026 Grand Prix scientifique of the NRJ Foundation - Institut de France for its brain-spine interface that restores movement to paralyzed patients.

.NeuroRestore wins part of France’s 2026 NRJ Foundation science grand prix

13 July 2026

Carewell, a Lausanne-based start-up whose platform helps Swiss healthcare institutions manage staff shortages, has raised CHF 1.5 million in a seed round to accelerate its expansion across Switzerland.

Carewell raises CHF 1.5 million to manage healthcare staff shortages

6 July 2026

Geneva has been named European Capital of Brain Health 2026 by the European Academy of Neurology, in recognition of its research and innovation ecosystem.

Geneva named European Capital of Brain Health 2026

6 July 2026

AC Immune will receive a USD 4 million research grant from The Vijay and Marie Goradia Charitable Foundation to extend Part 1 of the Phase 2 VacSYn trial of ACI-7104, its immunotherapy for early Parkinson's disease.

AC Immune secures USD 4 million grant to advance its Parkinson’s immunotherapy

6 July 2026

Geneva-based medtech company ABCDx has reached several milestones with LVOCheck, its point-of-care platform for diagnosing large vessel occlusion stroke, including a peer-reviewed publication, the completion of a Eurostars project and the start of its industrialization.

Geneva’s ABCDx reaches several milestones with its acute stroke diagnostics platform

29 June 2026

LEM Surgical, a Bern-based developer of robotic technologies for hard tissue surgery, has received a second FDA 510(k) clearance for its Dynamis Robotic Surgical System, adding new capabilities for spine surgery.

Bern-based LEM Surgical secures second FDA clearance for its Dynamis surgical robot

24 June 2026

At a recent BioAlps INSIDE event in Fribourg, the Biofactory Competence Center showcased how its bioprocess expertise helps partners across Western Switzerland move from research to production, with collaborations spanning Lausanne start-up Regenosca and the CHUV.

Fribourg’s Biofactory Competence Center turns biotech research into scalable production

23 June 2026

SOPHiA GENETICS, the Lausanne-based leader in AI-driven precision medicine, has closed an oversubscribed public offering with gross proceeds of USD 57.5 million to expand its platform, applications and partnerships.

SOPHiA GENETICS raises USD 57.5 million in oversubscribed public offering

22 June 2026

Impli, the deeptech company developing continuous molecular monitoring for hormonal health and present at Biopôle in Lausanne, has been awarded a GBP 1.4 million grant to bring its hormone-monitoring patch toward clinical validation for in vitro fertilization.

Impli secures GBP 1.4 million grant to advance continuous hormone monitoring for IVF

16 June 2026

Geneva-based femtech start-up TrialHer has converted early demand into paid pilots with two companies in the UK and Europe, and was selected to join the WHO/Europe Public Health Innovation Platform.

Geneva femtech TrialHer secures first paid pilots and WHO selection

15 June 2026

1 2 3 4 5 … 29